IEEE EMBS is an international society focused on biomedical engineering, serving as a central gathering point for engineering, medicine, and biology disciplines.

IEEE EMBS

The Canadian Medical and Biological Engineering Society is a professional organization focused on advancing and promoting the theory and practice of engineering sciences and technology in medicine and biology.

Canadian Medical and Biological Engineering Society

BioGaia AB (publ) develops, markets, and sells probiotic products with documented health benefits worldwide. It operates through three segments: Pediatrics, Adult Health, and Other. The Pediatrics segment offers drops, oral rehydration solutions, and gut health tablets, as well as cultures that are used as an ingredient in infant formula. The Adult Health segment provides gut health tablets and oral health lozenges products, as well as cultures, which are used as an ingredient in a licensee's dairy product. The Other segment provides packaging solutions. The company offers its products in the areas of infantile colic and digestive health in children; antibiotic-associated and acute diarrhoea; gingivitis; periodontal disease; general health; Helicobacter pylorithe gastric ulcer bacterium; and low bone density. It offers its products under the BioGaia brand name. BioGaia AB (publ) was founded in 1990 and is headquartered in Stockholm, Sweden.

BioGaia AB (publ)

Sonoma Biotherapeutics is a clinical-stage biotechnology company developing engineered regulatory T cell (Treg) therapies to treat serious autoimmune and inflammatory diseases by restoring balance to the immune system.

Metric
Company Name	IEEE EMBS	Canadian Medical and Biological Engineering Society	BioGaia AB (publ)	Sonoma Biotherapeutics
Symbol			BIOG-B
MSH ID	ORG:EMBS	CA:CMBES	COM:BIOGAIA	COM:SONOMABIO
Market	PRIVATE	PRIVATE	STOCKS	PRIVATE
Sector	Healthcare & Health Services	Healthcare & Health Services	Healthcare	Healthcare & Health Services
Industry	Biomedical Engineering	Biomedical Engineering	Drug Manufacturers - Specialty & Generic	Biotechnology
Country	US	CA	SE
Stage
Employee Count			211	101
Website	embs.org	cmbes.ca	biogaia.com	sonomabio.com
LinkedIn
Founders

Metric
Market Cap		1.10B
Enterprise Value
Monthly Web Traffic	266.31K
Web Traffic Growth	0.74
Valuation
Raised Capital

Metric
Revenue			118.62M
Revenue (LTM)
Revenue (NTM)
Gross Profit			86.94M
EBITDA			42.65M
Operating Income			40.34M
Net Income			33.43M
EPS			0.33
Diluted EPS			0.33
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin			0.81
Operating Profit Margin			0.35
EBITDA Margin			0.36
Net Profit Margin			0.29
Return on Equity			0.21
Return on Assets			0.21
Return on Capital Employed			0.28

ORG:EMBS

IEEE EMBS

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio			25.76
P/B Ratio			5.68
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio			10.08
EV Multiple			29.31

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding			190.98
Operating Cycle			139.97
Cash Conversion Cycle			88.00
Asset Turnover			0.72

Metric
Operating Cash Flow			38.97M
Free Cash Flow			34.53M
Cash Flow to Debt			12.05
Operating Cash Flow/Sales			0.33
Free Cash Flow Yield			0.03

Metric
Cash & Equivalents			141.28M
Accounts Receivable
Inventory
Goodwill			15.11M
Debt to Capitalization			0.02
Debt to Assets
Current Ratio			8.44
Quick Ratio			9.83

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue			0.09
SG&A to Revenue			0.03